Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Little

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Pharmacy and Pharmacology|May 11, 2024
The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic reviewWei Yu, Yaping Zhao, Iqra Ilyas, et al.
Journal of Cardiovascular Pharmacology|July 14, 2010
Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptorPeter J Little, Micah L Burch, Robel Getachew, et al.
The Journal of Pharmacy and Pharmacology|February 28, 2019
Endothelin-1 increases CHSY-1 expression in aortic endothelial cells via transactivation of transforming growth factor β type I receptor induced by type B receptor endothelin-1Faezeh Seif, Peter J Little, Reyhaneh Niayesh-Mehr, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2003
Troglitazone stimulates repair of the endothelium and inhibits neointimal formation in denuded rat aortaKatherine M Hannan, Rodney J Dilley, Stephanie T de Dios, et al.
Atherosclerosis|July 22, 2011
Cardiovascular actions and therapeutic potential of tanshinone IIASi Gao, Zhiping Liu, Hong Li, et al.
Atherosclerosis|February 17, 2009
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDLMandy L Ballinger, Melanie E Ivey, Narin Osman, et al.
The Journal of Pharmacy and Pharmacology|April 27, 2019
Treatment of atherosclerotic plaque: perspectives on theranosticsYicong Zhang, Aayushi Koradia, Danielle Kamato, et al.
ACS Biomaterials Science & Engineering|April 2, 2021
Poly(aspartic acid) in Biomedical Applications: From Polymerization, Modification, Properties, Degradation, and Biocompatibility to ApplicationsHossein Adelnia, Huong D N Tran, Peter J Little, et al.
Pharmacology & Therapeutics|November 16, 2018
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeuticsSuowen Xu, Danielle Kamato, Peter J Little, et al.
Journal of Cell Communication and Signaling|February 8, 2017
Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptorsRebecca Chaplin, Lyna Thach, Morley D Hollenberg, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Pharmacy and Pharmacology|May 11, 2024
The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic reviewWei Yu, Yaping Zhao, Iqra Ilyas, et al.
Journal of Cardiovascular Pharmacology|July 14, 2010
Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptorPeter J Little, Micah L Burch, Robel Getachew, et al.
The Journal of Pharmacy and Pharmacology|February 28, 2019
Endothelin-1 increases CHSY-1 expression in aortic endothelial cells via transactivation of transforming growth factor β type I receptor induced by type B receptor endothelin-1Faezeh Seif, Peter J Little, Reyhaneh Niayesh-Mehr, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2003
Troglitazone stimulates repair of the endothelium and inhibits neointimal formation in denuded rat aortaKatherine M Hannan, Rodney J Dilley, Stephanie T de Dios, et al.
Atherosclerosis|July 22, 2011
Cardiovascular actions and therapeutic potential of tanshinone IIASi Gao, Zhiping Liu, Hong Li, et al.
Atherosclerosis|February 17, 2009
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDLMandy L Ballinger, Melanie E Ivey, Narin Osman, et al.
The Journal of Pharmacy and Pharmacology|April 27, 2019
Treatment of atherosclerotic plaque: perspectives on theranosticsYicong Zhang, Aayushi Koradia, Danielle Kamato, et al.
ACS Biomaterials Science & Engineering|April 2, 2021
Poly(aspartic acid) in Biomedical Applications: From Polymerization, Modification, Properties, Degradation, and Biocompatibility to ApplicationsHossein Adelnia, Huong D N Tran, Peter J Little, et al.
Pharmacology & Therapeutics|November 16, 2018
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeuticsSuowen Xu, Danielle Kamato, Peter J Little, et al.
Journal of Cell Communication and Signaling|February 8, 2017
Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptorsRebecca Chaplin, Lyna Thach, Morley D Hollenberg, et al.
Pageof 19